ARCHIVES

In Brief: PHS Established Two Scientific Integrity Offices; Workshop On Ethical Issues Planned

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

NCI Conducting Four Epidemiology Studies On Radon

July 1, 1988

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995